» Articles » PMID: 11849870

Is Electrical Stimulation During Administration of Catecholamines Required for the Evaluation of Success After Ablation of Atrioventricular Node Re-entrant Tachycardias?

Overview
Date 2002 Feb 19
PMID 11849870
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The purpose of this study was to answer the question of whether stimulation after administration of catecholamines is mandatory for identifying unsuccessful ablations of atrioventricular node re-entrant tachycardia (AVNRT).

Background: The success of radiofrequency (RF) catheter ablation in AVNRT is confirmed in many centers by noninducibility of tachycardias during stimulation after the administration of catecholamines.

Methods: A total of 131 patients (81 women and 50 men; mean age 53.6 +/- 13.7 years [range 20 to 77]) were studied. Electrical stimulation was performed without and with the beta-adrenergic amine Orciprenaline (metaproterenol) before and after RF catheter ablation.

Results: In 100 patients (76.3%; confidence interval [CI] 68.1% to 83.3%) an AVNRT was inducible without administration of Orciprenaline. Thirty minutes after the initially successful ablation in 95 patients, tachycardia was inducible in none of these patients, not even after Orciprenaline administration. In the 31 patients (23.7%; CI 16.7% to 31.9%) in whom there was no tachycardia inducible before ablation, Orciprenaline was given, and the stimulation protocol was repeated. In only five patients (3.8%; CI 1.3% to 8.7%) was there still no tachycardia inducible. After an initially successful ablation in the 26 patients who had inducible tachycardias with Orciprenaline before ablation, no tachycardia could be re-induced. After Orciprenaline, the tachycardia was inducible again in only one patient.

Conclusions: Only patients who require catecholamines for tachycardia induction before ablation need catecholamines for control of the success of the ablation of AVNRT.

Citing Articles

Evaluation of the effects of isoproterenol on arrhythmia recurrence following catheter ablation in patients with atrioventricular nodal re-entrant tachycardia: A randomized controlled clinical trial.

Vahid Lotfabadi N, Mehrabi S, Heidari-Bakavoli A, Morovatdar N, Tayyebi M, Baradaran Rahimi V Pharmacol Res Perspect. 2023; 11(2):e01068.

PMID: 36855813 PMC: 9975462. DOI: 10.1002/prp2.1068.


Role of isoproterenol in predicting the success of catheter ablation in patients with reproducibly inducible atrioventricular nodal reentrant tachycardia.

Heydari A, Tayyebi M, Jami R, Amiri A Tex Heart Inst J. 2014; 41(3):280-5.

PMID: 24955042 PMC: 4060335. DOI: 10.14503/THIJ-13-3332.


Recurrent supraventricular tachycardias prevalence and pathophysiology after RF ablation: A 5-year registry.

Hussien K, Hammouda M, Elakbawy H, Abdelaziz A, Abdelaal A, Shehata M J Saudi Heart Assoc. 2013; 21(4):221-8.

PMID: 23960578 PMC: 3727369. DOI: 10.1016/j.jsha.2009.10.005.